) The applicant seeks to develop a cost effective surface plasmon resonance spectrometer capable of analyzing biospecific interactions for both research and clinical uses. Both long and short range plasmon analysis will be incorporated into the instrument and allow a multiplexed analysis of a number of sample sites using a charge-coupled detector (CCD). A conventional prism-diode rotating stage analysis protocol will be used. In addition, novel substrates will be developed including preparation of thin robust films of silver-gold alloys and self-assembled monolayers of silane-gold films. The detection is based on surface immobilization of an antibody on a substrate slide bed. When the analyte binds to the immobilized antibody the resulting change in thickness is detected via a change in refractivity and corresponding surface plasmon spectrum, reflectivity versus angle. This can be used to provide qualitative and quantitative proof of protein binding and can also be used to probe binding kinetics and mechanism of binding.

Proposed Commercial Applications

NOT AVAILABLE

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41RR011764-01A2
Application #
2647168
Study Section
Special Emphasis Panel (ZRG2-SSS-4 (02))
Project Start
1998-06-01
Project End
1999-05-31
Budget Start
1998-06-01
Budget End
1999-05-31
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Detection Limit, Inc.
Department
Type
DUNS #
City
Laramie
State
WY
Country
United States
Zip Code
82070